Archive for September, 2011
Recent Rosacea Blog Posts
A vaccine for acne ? Well it appears that one may actually become a reality. A recent article in the New Scientists explains how targeting a protein called CAMP can lead to a form of Propionibacterium acnes (the believed main culprit in acne) that can function but not produce the inflammation that leads to acne. […]
A recently posted proposed Clinical Trial has me thinking that Galderma wants to be able to market Oracea as a product to Maintain Rosacea Remission. First Some History In 1998, Archives of Dermatology published a much quoted paper Topical Metronidazole Maintains Remissions of Rosacea. (the PDF of the full paper is available online). The premise […]
More from the weird and wonderful world of clinical trials and the mysterious Placebo Effect. We know that somehow even dummy pills can kick-start the body’s recovery engine. This latest article from WIRED tells us that drug developers are noticing that over time that the placebo effect is increasing. Drugs that once clearly outperformed placebo […]
Over at the Acne Blog, Daniel Kern has posted a few high level posts relating to recent readings he has undertaken on the topic of diet and acne. Daniel has read the latest published research to see what new trends are emerging. It is encouraging to see that research is continuing in this area. Long […]
An interesting note from the detailed interim judgement in the ongoing patent dispute between Galderma and Mylan. As part of the proceedings Mylan looked at the on-going Oracea sales and projected that Galderma can expect to receive around $260 million in 2011. MYLAN PHARMACEUTICALS INC., v. GALDERMA LABORATORIES, L.P.; et. al. Mylan projected that Oracea’s […]
